Page last updated: 2024-09-03

2-n-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine and Diabetes Mellitus

2-n-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine has been researched along with Diabetes Mellitus in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brozinick, JT; Cushman, SW; Gibbs, EM; Hargrove, DM; McCoid, SC; Nardone, NA; Reynolds, TH; Stevenson, RW1

Other Studies

1 other study(ies) available for 2-n-(4-(1-azitrifluoroethyl)benzoyl)-1,3-bis-(mannos-4-yloxy)-2-propylamine and Diabetes Mellitus

ArticleYear
GLUT4 overexpression in db/db mice dose-dependently ameliorates diabetes but is not a lifelong cure.
    Diabetes, 2001, Volume: 50, Issue:3

    Topics: Animals; Azides; Biological Transport; Cell Membrane; Deoxyglucose; Diabetes Mellitus; Disaccharides; Dose-Response Relationship, Drug; Glucose Clamp Technique; Glucose Tolerance Test; Glucose Transporter Type 4; Glycosides; Humans; Hypoglycemic Agents; Insulin; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monosaccharide Transport Proteins; Muscle Proteins; Propylamines

2001